Singapore’s Health Ministry recently announced a series of initiatives representing a shift in healthcare policy, with a greater emphasis on preventative care. Health Minister Ong Ye Kung stated on March 8 that these changes, while not “huge policy changes,” mark a re-examination of long-held assumptions.
A Focus on Prevention
A key change is the planned extension of MediShield Life to cover preventative surgery, a first for the national health insurance scheme. According to Mr. Ong, preventative care is both cost-effective and reduces the need for more intensive treatment later on. He emphasized that “the best way to contain healthcare costs is to stay healthy,” and that this is central to the country’s healthcare transformation.
Evolving Role of MediSave
The Ministry is likewise reassessing the role of MediSave, Singapore’s national medical savings scheme. Initially intended as a fund for emergencies, MediSave will now also support preventative care and chronic disease management. Mr. Ong acknowledged that balancing these dual objectives—saving for emergencies versus proactive health measures—presents a challenge, and that increasing contributions may need to be considered if the tension becomes too severe.
MediSave Withdrawal Limits
From January 1, 2027, withdrawal limits under the MediSave 500/700 scheme will be raised to $700 and $1,000 respectively. The scheme, which allows withdrawals for chronic disease management and preventative tests, will be renamed the MediSave Chronic and Preventive Care scheme. The Chronic Disease Management Programme (CDMP), covering 23 major conditions, will also expand to include thyroid disorders, with plans to add conditions like eczema in the future.
Leveraging Technology
Mr. Ong highlighted the potential of artificial intelligence (AI) to enhance healthcare screenings. The Assisted Chronic Disease Explanation using AI (ACE-AI) tool will be rolled out to doctors for all Healthier SG participants from early 2027. This tool will support identify individuals at high risk of developing diabetes or high cholesterol, triggering annual cardiovascular disease risk screenings for those with a greater than 75% chance of diagnosis.
Frequently Asked Questions
What is the MediSave Chronic and Preventive Care scheme?
It is the renamed MediSave 500/700 scheme, with increased withdrawal limits of $700 and $1,000, designed to support both chronic disease management and preventative care.
What is the ACE-AI tool?
The ACE-AI tool is an artificial intelligence-powered tool that will be rolled out to doctors in early 2027 to help identify individuals at high risk of developing diabetes or high cholesterol.
Will data from the ACE-AI tool be shared?
According to Mr. Ong, the data will be kept confidential and shared only between the doctor and the patient.
As Singapore’s population ages, how might these changes in healthcare policy impact the long-term sustainability of the national healthcare system?
